Modified poly(L-lysine)-based structures as novel antimicrobials for diabetic foot infections, an in-vitro study.

Data used to generate Figures 2 to 7 Figure 2. Bactericidal activity of poly-L-lysine polymers against S. aureus and P. aeruginosa laboratory strains compared to antibiotics. Figure 3. Bactericidal activity of poly-L-lysine polymers against S. aureus and P. aeruginosa laboratory strains. Figure 4. Comparative bactericidal activity of poly-L-lysine G3(16) copolymers series with hydrophobic amino acid isoleucine, tyrosine and phenylalanine. Figure 5. Comparison of Bactericidal activity of poly-L-lysine polymers, PLL160 and G2(8)PLL20 against S. aureus clinical isolates from wound infections. Figure 6. Bactericidal activity of linear PLL160 against S. aureus and P. aeruginosa isolates from suspected diabetic foot infections. Figure 7. Investigation of PLL polymer-induced loss of biofilm viability by resazurin staining of 24 h biofilms.